Vancouver-based Light AI launched on Cboe Canada, trading under ALGO, aiming to revolutionize medical diagnostics. Armed with $20 million in R&D since 2016, its AI algorithms analyze smartphone images to detect Strep A infections, eliminating the need for traditional swabbing. Pre-FDA studies show a 97% accuracy rate, equivalent to swabs.
CEO Peter Whitehead envisions expanding the AI-powered tech to other conditions like skin and eye disorders. Light AI’s 300,000-image pharyngitis database underpins its technology, touted as a step toward a “Digital Clinical Lab” offering rapid, accessible diagnoses.
Want to know more? Check out the source code on Techcouver.